Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant
Uncategorized December 22, 2021
Ryan Allway December 22nd, 2021 Uncategorized BURLINGTON, Ontario, December 22, 2021–(BUSINESS WIRE)–Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company“) (CSE: DOSE) and McMaster University (“McMaster“) are pleased to announce that the ongoing development of an orally delivered vaccine candidate for COVID-19 has received the final installment of the... Read more
Ryan Allway April 7th, 2021 Psychedelics DENVER, April 07, 2021 — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, has announced its four lead novel drug candidates... Read more
